Revance Therapeutics Statistics
Total Valuation
ODFL has a market cap or net worth of $29.98 billion. The enterprise value is $30.12 billion.
Important Dates
The last earnings date was Wednesday, July 30, 2025, before market open.
| Earnings Date | Jul 30, 2025 |
| Ex-Dividend Date | Sep 3, 2025 |
Share Statistics
ODFL has 211.33 million shares outstanding. The number of shares has decreased by -2.29% in one year.
| Current Share Class | 211.33M |
| Shares Outstanding | 211.33M |
| Shares Change (YoY) | -2.29% |
| Shares Change (QoQ) | -0.62% |
| Owned by Insiders (%) | 8.00% |
| Owned by Institutions (%) | 77.96% |
| Float | 194.27M |
Valuation Ratios
The trailing PE ratio is 27.71 and the forward PE ratio is 28.26. ODFL's PEG ratio is 2.07.
| PE Ratio | 27.71 |
| Forward PE | 28.26 |
| PS Ratio | 5.35 |
| Forward PS | 4.91 |
| PB Ratio | 7.08 |
| P/TBV Ratio | 7.09 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 2.07 |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 27.51 |
| EV / Sales | 5.34 |
| EV / EBITDA | 16.87 |
| EV / EBIT | 21.04 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.38, with a Debt / Equity ratio of 0.04.
| Current Ratio | 1.38 |
| Quick Ratio | 1.38 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.09 |
| Debt / FCF | n/a |
| Interest Coverage | 27,535.21 |
Financial Efficiency
Return on equity (ROE) is 26.25% and return on invested capital (ROIC) is 20.88%.
| Return on Equity (ROE) | 26.25% |
| Return on Assets (ROA) | 16.43% |
| Return on Invested Capital (ROIC) | 20.88% |
| Return on Capital Employed (ROCE) | 28.39% |
| Revenue Per Employee | $257,530 |
| Profits Per Employee | $50,012 |
| Employee Count | 21,895 |
| Asset Turnover | 1.04 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ODFL has paid $339.12 million in taxes.
| Income Tax | 339.12M |
| Effective Tax Rate | 23.65% |
Stock Price Statistics
The stock price has decreased by -32.51% in the last 52 weeks. The beta is 1.25, so ODFL's price volatility has been higher than the market average.
| Beta (5Y) | 1.25 |
| 52-Week Price Change | -32.51% |
| 50-Day Moving Average | 162.24 |
| 200-Day Moving Average | 179.27 |
| Relative Strength Index (RSI) | 28.57 |
| Average Volume (20 Days) | 1,876,029 |
Short Selling Information
The latest short interest is 10.04 million, so 4.75% of the outstanding shares have been sold short.
| Short Interest | 10.04M |
| Short Previous Month | 10.21M |
| Short % of Shares Out | 4.75% |
| Short % of Float | 5.17% |
| Short Ratio (days to cover) | 5.74 |
Income Statement
In the last 12 months, ODFL had revenue of $5.64 billion and earned $1.10 billion in profits. Earnings per share was $5.12.
| Revenue | 5.64B |
| Gross Profit | 2.22B |
| Operating Income | 1.43B |
| Pretax Income | 1.69B |
| Net Income | 1.10B |
| EBITDA | 1.79B |
| EBIT | 1.43B |
| Earnings Per Share (EPS) | $5.12 |
Full Income StatementBalance Sheet
The company has $24.06 million in cash and $169.99 million in debt, giving a net cash position of -$145.94 million or -$0.69 per share.
| Cash & Cash Equivalents | 24.06M |
| Total Debt | 169.99M |
| Net Cash | -145.94M |
| Net Cash Per Share | -$0.69 |
| Equity (Book Value) | 4.23B |
| Book Value Per Share | 20.04 |
| Working Capital | 191.28M |
Full Balance SheetMargins
Gross margin is 39.39%, with operating and profit margins of 25.39% and 19.42%.
| Gross Margin | 39.39% |
| Operating Margin | 25.39% |
| Pretax Margin | 25.43% |
| Profit Margin | 19.42% |
| EBITDA Margin | 31.67% |
| EBIT Margin | 25.39% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of $1.12, which amounts to a dividend yield of 0.75%.
| Dividend Per Share | $1.12 |
| Dividend Yield | 0.75% |
| Dividend Growth (YoY) | 12.24% |
| Years of Dividend Growth | 8 |
| Payout Ratio | 21.49% |
| Buyback Yield | 2.29% |
| Shareholder Yield | 3.08% |
| Earnings Yield | 3.65% |
| FCF Yield | n/a |
Dividend DetailsAnalyst Forecast
The average price target for ODFL is $171.84, which is 21.14% higher than the current price. The consensus rating is "Buy".
| Price Target | $171.84 |
| Price Target Difference | 21.14% |
| Analyst Consensus | Buy |
| Analyst Count | 22 |
| Revenue Growth Forecast (5Y) | 6.55% |
| EPS Growth Forecast (5Y) | 10.27% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on March 28, 2024. It was a forward split with a ratio of 2:1.
| Last Split Date | Mar 28, 2024 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |
